• Bloomberg

  • SHARE

Novavax Inc.’s COVID-19 vaccine was cleared by U.S. regulators, giving Americans another tool against the virus as cases start to rise again.

The U.S. Food and Drug Administration’s nod makes Novavax’s the first vaccine authorized for adults that mimics the protein that the coronavirus uses to enter cells.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)